> On 8 Jul, 04:16, p.clar...[at]gmail.com wrote:
> > On Jul 7, 8:58 am, Kisame Hoshigaki <absolutelyinvinci...[at]hotmail.com> > wrote:
> > > Dear pclar,
> > > p.clar...[at]gmail.com wrote:
> > > > The results of this study do not support the hypothesis
> > > > that an overcorrected myope has a lower rate of increase of myopia
> > > > than a myope wearing a conventional spectacle correction.
> > > I do not understand what you mean here. Are you saying that this study
> > > supports the view that: overcorrected myope has a lower rate of
> > > increase in myopia than a myope wearing conventional spectacle
> > > correction or that: an overcorrected myopia has a *higher* rate rate
> > > of increase of myopia than a myope wearing a conventional spectacle
> > > correction. The studies appear to agree with the latter view.
> > > -KH
> > wow. i thought the study was pretty clear.
> > the study shows that there is NO DIFFERENCE in myopia progression in
> > human children who were overcorrected with excessive minus lens power
> > versus children who were properly corrected. in other words, using
> > excessive amounts of the "wretched minus" has no impact on the myopia
> > development. to put it another way, excessive minus lens power DOES
> > NOT induce stairstep myopia.
> Dear pclar,
> I very much apologize, I only skimmed through it very fast when I read
> it first time round. So I missed the end conclusion LOL. Thx for
> clarifying. Btw. what do you mean by 'stearsteps' myopia?? (Sorry, I
> am still a newbie to all this complex stuff. But I am learning lots!!)

> On Jul 7, 8:58 am, Kisame Hoshigaki <absolutelyinvinci...[at]hotmail.com> wrote:
> > Dear pclar,
> > p.clar...[at]gmail.com wrote:
> > > The results of this study do not support the hypothesis
> > > that an overcorrected myope has a lower rate of increase of myopia
> > > than a myope wearing a conventional spectacle correction.
> > I do not understand what you mean here. Are you saying that this study
> > supports the view that: overcorrected myope has a lower rate of
> > increase in myopia than a myope wearing conventional spectacle
> > correction or that: an overcorrected myopia has a *higher* rate rate
> > of increase of myopia than a myope wearing a conventional spectacle
> > correction. The studies appear to agree with the latter view.
> > -KH
> wow. i thought the study was pretty clear.
> the study shows that there is NO DIFFERENCE in myopia progression in
> human children who were overcorrected with excessive minus lens power
> versus children who were properly corrected. in other words, using
> excessive amounts of the "wretched minus" has no impact on the myopia
> development. to put it another way, excessive minus lens power DOES
> NOT induce stairstep myopia.

> On Jul 7, 10:53 pm, "otisbr...[at]pa.net" <otisbr...[at]pa.net> wrote:
> > Otis> Here is Neil DBG Brooks original post -- to which
> > I typed in these responses:
> are you still blathering? you know there is a discussion going on in
> this very thread which brings into question your whole concept of
> myopiagenesis being induced by minus lenses. why don't you take a
> moment and read it and comment. this experiment, which was performed
> in humans rather than your beloved Young experiment which was done on
> monkeys, shows that minus lenses have ZERO detrimental effect.
> what is your critical evaluation of this paper (Goss et. al)? Or are
> you going to just cut and run like you always do?

> Otis> Here is Neil DBG Brooks original post -- to which
> I typed in these responses:

> "RT" <RTM...[at]NOSPAMyahoo.com> wrote
> > > The results of this study do not support the hypothesis
> > > that an overcorrected myope has a lower rate of increase of myopia
> > > than a myope wearing a conventional spectacle correction.
> > This wording is kind of tricky isn't? This study was testing the
> > hypothesis that myopes can reduce their myopia by overcorrecting. I
> > haven't seen anyone argue that on this NG.
> The weird hypothesis could be a novel approach for the sake of pleasing the
> editors. It's probably difficult to get _another_ paper published that
> simply says overcorrection does no significant harm.
> -MT

> Dear pclar,
> p.clar...[at]gmail.com wrote:
> > The results of this study do not support the hypothesis
> > that an overcorrected myope has a lower rate of increase of myopia
> > than a myope wearing a conventional spectacle correction.
> I do not understand what you mean here. Are you saying that this study
> supports the view that: overcorrected myope has a lower rate of
> increase in myopia than a myope wearing conventional spectacle
> correction or that: an overcorrected myopia has a *higher* rate rate
> of increase of myopia than a myope wearing a conventional spectacle
> correction. The studies appear to agree with the latter view.
> -KH

> In article <1183778848.526528.276...[at]k79g2000hse.googlegroups.com> ,
> p.clar...[at]gmail.com wrote:
> > The results of this study do not support the hypothesis
> > that an overcorrected myope has a lower rate of increase of myopia
> > than a myope wearing a conventional spectacle correction.
> This wording is kind of tricky isn't? This study was testing the
> hypothesis that myopes can reduce their myopia by overcorrecting. I
> haven't seen anyone argue that on this NG.
> In fact the experimental group (the overcorrected group) GAINED slightly
> more myopia (Otis's hypothesis)--the gain was statistically
> insignificant, but it was a gain nonetheless.
> (disclaimer--in support or against no one. just reacting to a post.)
> --
> ~RT

> Otis> Here is Neil DBG Brooks original post -- to which
> I typed in these responses:

> Please Forward Widely

> Unite For Sight Fifth Annual International Health & Eye Care
> Conference
> Building Global Health For Today and Tomorrow
> April 12-13, 2008
> Yale University, New Haven, Connecticut
> http://www.uniteforsight.org/conference/2008

> Please Forward Widely
> Unite For Sight Fifth Annual International Health & Eye Care
> Conference
> Building Global Health For Today and Tomorrow
> April 12-13, 2008
> Yale University, New Haven, Connecticuthttp://www.uniteforsight.org/conference/2008
> Join 2,000 conference attendees and 130 speakers for a stimulating
> conference.
> Keynote Addresses By: Dr. Jeffrey Sachs, Dr. Sonia Sachs, Dr. Susan
> Blumenthal, and Dr. Jim Yong Kim
> Plus More Than 130 Featured Speakers
> Call For Abstracts - DEADLINE JULY 15, 2007 -http://uniteforsight.org/conference/2008/abstracts.php
> Register For Conference - EARLY BIRD RATE ($45 Students, $70 All
> Others) http://www.uniteforsight.org/conference/2008REGISTER BY JULY
> 15th TO SECURE LOWEST RATE
> Who should attend? Anyone interested in eye care, international
> health, public health, international development, medicine, social
> entrepreneurship, nonprofits, philanthropy, microfinance, bioethics,
> anthropology, health policy, advocacy, and public service.
> *Keynote Addresses*
> * Susan Blumenthal, MD, MPA, Former U.S. Assistant Surgeon
> General; Senior Advisor For Health and Medicine; Former Deputy
> Assistant Secretary for Women's Health, U.S. Department of Health and
> Human Services; Clinical Professor of Psychiatry at Georgetown School
> of Medicine and Tufts University Medical Center
> * Jim Yong Kim, MD, PhD, Co-Founder, Partners in Health; Director,
> François Xavier Bagnoud Center for Health and Human Rights; François
> Xavier Bagnoud Professor of Health and Human Rights, Harvard School of
> Public Health; Chair, Department of Social Medicine, Harvard Medical
> School; Chief of the Division of Social Medicine and Health
> Inequalities, Brigham and Women's Hospital; Former HIV/AIDS Director
> at World Health Organization
> * Jeffrey Sachs, PhD, Director of Earth Institute at Columbia
> University; Quetelet Professor of Sustainable Development, Professor
> of Health Policy and Management, Columbia University; Special Advisor
> to Secretary-General of the United Nations Ban Ki-moon
> * Sonia Sachs, MD, MPH, Health Coordinator, Millennium Villages
> *130 Featured Speakers (Listed Below Are The Speakers Confirmed Thus
> Far)*
> * Ted M. Alemayhu, Founder, Chairman and CEO, US Doctors For
> Africa
> * Greg Allgood, PhD, Director, Children's Safe Drinking Water,
> Procter & Gamble
> * R. Rand Allingham, MD, Professor of Ophthalmology; Director,
> Glaucoma Service, Duke University Eye Center
> * Jared Ament, MD, MPh, Clinical Research Fellow, Ophthalmolology
> & Corneal Surgery, Massachusetts Eye and Ear Infirmary, Harvard
> Medical School; Harvard School of Public Health
> * Jane Aronson, MD, Director, International Pediatric Health
> Services; Founder and Executive Medical Director, Worldwide Orphans
> Foundation (WWO); Clinical Assistant Professor of Pediatrics, Weill
> Medical College of Cornell University
> * Thomas Baah, MD, MSc, Ophthalmologist, Our Lady of Grace
> Hospital, Ghana
> * Michele Barry, MD, FACP, Professor of Medicine and Global Health
> Director, Office of International Health; Chief, General Medicine
> Firm, Yale University School of Medicine
> * Georges Benjamin, MD, Executive Director, American Public Health
> Association
> * Paul Berman, OD, FAAO, Senior Global Clinical Advisor and
> Founder, Special Olympics Lions Clubs, International Opening Eyes
> * Terry Blaschke, MD, Professor of Medicine and of Molecular
> Pharmacology (Active Emeritus), Stanford University School of Medicine
> * Neil Boothby, EdD, Professor of Clinical Population and Family
> Health; Director, Program on Forced Migration and Health, Mailman
> School of Public Health
> * Harry S. Brown, MD, Founder, Surgical Eye Expeditions (SEE)
> International
> * Donald Budenz, MD, MPH, Professor of Ophthalmology,
> Epidemiology, and Public Health, University of Miami Miller School of
> Medicine
> * Michael Cappello, MD, Professor of Pediatrics and Epidemiology
> and Public Health; Director, Program in International Child Health; Co-
> Director, International Adoption Clinic, Yale University School of
> Medicine
> * Emily Moore and Mark Carlson, PhD, Adjunct Professor, Sociology,
> San Diego State University
> * James Clarke, MD, Ophthalmologist and Medical Director, Crystal
> Eye Clinic, Ghana
> * Susan Day, MD, Chair and Program Director, Pediatric
> Ophthalmology and Strabismus, California Pacific Medical Center
> * Syril Dorairaj, MD, Clinical Research Fellow, Glaucoma
> Associates of New York, The New York Eye and Ear Infirmary
> * Margaret Duah-Mensah, Ophthalmic Nurse, Crystal Eye Clinic,
> Ghana
> * Andy Ellner, MD, Clinton HIV/AIDS Initiative
> * Sheri Fink, MD, PhD, Kaiser Media Fellow in Global Health;
> Visiting Scientist, Francois-Xavier Bagnoud Center for Health and
> Human Rights, Harvard School of Public Health; Senior Fellow, Harvard
> Humanitarian Initiative
> * Susan Hall Forster, MD, Associate Clinical Professor, Department
> of Medical Studies, Department of Ophthalmology, Yale School of
> Medicine; Chief, Ophthalmology, Yale University Health Services
> * David Friedman, MD, MPH, Associate Professor of Ophthalmology
> and International Health, Johns Hopkins University
> * Urick Gaillard, JD, Founder and Executive Director, The Batey
> Relief Alliance
> * Gabriel Garcia, MD, Professor of Medicine, Associate Dean of
> Medical School Admissions, Stanford University School of Medicine
> * Nora Groce, PhD, Associate Professor and Director, Yale/WHO
> Collaborating Centre, Global Health Division, Yale School of Public
> Health
> * Michael Gyasi, MD, Ophthalmologist and Director of the Bawku Eye
> Care Program, Ghana
> * Heskel M. Haddad, MD, Clinical Professor of Ophthalmology, New
> York Medical College
> * Leon Herndon, MD, Associate Professor of Ophthalmology, Duke
> University Eye Center
> * Ibrahim Jabr, Interim President, International Trachoma
> Initiative
> * Rosemary Janiszewski, MS, CHES, Deputy Director, Office of
> Communication, Health Education and Public Liaison; Director, National
> Eye Health Eucation Program, National Eye Institute (NEI), National
> Institutes of Health
> * Evaleen Jones, MD, Founder, President and Medical Director,
> Child Family Health International; Clinical Assistant Professor,
> Stanford University School of Medicine
> * Dean Karlan, PhD, President and Founder of Innovations for
> Poverty Action; Assistant Professor of Economics, Yale University
> * Zachary Kaufman, MPhil in International Relations; DPhil
> Candidate in International Relations, University of Oxford; JD
> Candidate, Yale University Law School
> * Kaveh Khoshnood, PhD, Assistant Professor in Public Health
> Practice, Division of Epidemiology of Microbial Diseases, Yale School
> of Public Health
> * Doug Lawrence, Vice President/General Manager, BD Medical -
> Ophthalmic Systems
> * Fiona Macaulay, President, Making Cents International
> * Carolyn Makinson, PhD, Executive Director, Women's Commission
> for Refugee Women and Children
> * Tshepo Mbalambi, BSc, Med Sci, MBcHB Candidate, University of
> Ghana School of Medicine
> * John McGoldrick, Senior Vice President, International AIDS
> Vaccine Initiative (IAVI)
> * Christine Melton, MD, MS, Friends of Aravind Association
> * Mini Murthy, MD, MPH, MS, Assistant Professor, Department of
> Behavioral Science and Community Health, Program Director Global
> Health, New York Medical College School of Public Health
> * Neal Nathanson, MD, Associate Dean, Global Health Programs,
> University of Pennsylvania School of Medicine
> * Thomas Novotny, MD, MPH, Director of International Programs;
> Professor in Residence, Epidemiology and Biostatistics, UCSF School of
> Medicine
> * Edward O'Neil Jr, MD, Founder, Omni Med; Author, Awakening
> Hippocrates: Primer on Health, Poverty, and Global Service, and A
> Practical Guide to Global Health Service
> * Cliff OCallahan, MD, PhD, Pediatric Faculty, Middlesex Hospital
> Family Practice Program; Chair, AAP Section on International Child
> Health
> * Adeyemi Oshodi, PATH
> * Elijah Paintsil, MD, Associate Research Scientist, Department of
> Pediatrics, Yale School of Medicine
> * Matthew Paul, MD, Danbury Eye Physicians and Surgeons
> * Steven C. Phillips, MD, MPH, Medical Director, Global Issues and
> Projects, Exxon Mobil Corporation
> * Louis Pizzarello, MD, MPH, Secretary General, International
> Agency for the Prevention of Blindness
> * Thomas Quinn, MD, Director, Johns Hopkins Center for Global
> Health
> * Nathan Radcliffe, MD, Glaucoma Service at New York Eye & Ear
> Infirmary
> * Ian Rawson, MD, CEO/Directeur General, Hopital Albert Schweitzer
> Haiti
> * William Reese, President and CEO, International Youth Foundation
> * Ilya Rozenbuam, MD, GANY Glaucoma Fellow, New York Eye and Ear
> Institute
> * Leonard Rubenstein, Executive Director, Physicians for Human
> Rights
> * Jennifer Ruger, PhD, MSc, Assistant Professor, Division of
> Global Health, Yale School of Public Health; Co-Director of the Yale/
> World Health Organization (WHO) Collaborating Centre for Health
> Promotion, Policy and Research; Interdisciplinary Research Methods
> Core Investigator, Center for Interdisciplinary Research on AIDS
> * Lisa Russell, MPH, Filmmaker
> * Sarwat Salim, MD, Ophthalmologist
> * Sarang Samal, Kalinga Eye Hospital, Orissa, India
> * Georgia Sambunaris, MA
> * Werner Schultink, MD, Chief Child Development and Nutrition,
> UNICEF
> * Chirag Shah, MD, Chief Resident, Wills Eye Hospital
> * Bruce Shields, MD, Professor of Ophthalmology, Chairman
> Emeritus, Department of Ophthalmology, Yale University School of
> Medicine
> * Satyajit Sinha, MBBS, Ophthalmologist, AB Eye Institute, Patna,
> India
> * D. Scott Smith, MD, MSc, DTM&H, Chief of Infectious Disease and
> Geographic Medicine, Kaiser Redwood City Hospital
> * Eliot Sorel, MD, D.L.F.A.P.A. Global Health, Health Services
> Management, and Leadership, The George Washington University School of
> Public Health; Psychiatry & Behavioral Sciences School of Medicine,
> GWU; Chairman, Founder, Conflict ...
> read more »